Enhanced endothelin-1 system activity with overweight and obesity (Q35314860)

7 August 2017

Enhanced endothelin-1 system activity with overweight and obesity (English)

1 reference

7 August 2017

0 references

Brian L Stauffer

5

0 references

author name string

Brian R Weil

1

1 reference

7 August 2017

Christian M Westby

2

1 reference

7 August 2017

Gary P Van Guilder

3

1 reference

7 August 2017

Jared J Greiner

4

1 reference

7 August 2017

Christopher A DeSouza

6

1 reference

7 August 2017

10 June 2011

1 reference

American Journal of Physiology Heart and Circulatory Physiology

7 August 2017

1 reference

7 August 2017

301

1 reference

7 August 2017

H689-95

1 reference

7 August 2017

3

1 reference

At the heart of tissue: endothelin system and end-organ damage

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Diagnosis and classification of diabetes mellitus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Endothelin-1, aging and hypertension.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Mechanisms of ET-1-induced endothelial dysfunction

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Vascular endothelin in hypertension

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Endothelin, angiotensin, and oxidative stress in hypertension

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Role of endothelin in human hypertension

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Pathophysiology of endothelin in the cardiovascular system

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Insulin stimulates production and secretion of endothelin from bovine endothelial cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Polar secretion of endothelin-1 by cultured endothelial cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Weight and blood pressure. Findings in hypertension screening of 1 million Americans.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Increased activity of endogenous endothelin in patients with type II diabetes mellitus

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Role of endothelin in the increased vascular tone of patients with essential hypertension

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191085

Endothelin-1–Induced Vasopressor Responses in Essential Hypertension

26 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1152%2FAJPHEART.00206.2011

Obesity and cardiovascular disease

21 January 2018

1 reference

12 December 2020

Incidence and precursors of hypertension in young adults: the Framingham Offspring Study

1 reference

12 December 2020

Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study

1 reference

12 December 2020

Impaired vasoconstriction to endothelin 1 in patients with NIDDM

1 reference

12 December 2020

Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans

1 reference

12 December 2020

Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity

1 reference

12 December 2020

The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people

1 reference

12 December 2020

Endothelin and oxidative stress in the vascular system

1 reference

12 December 2020

Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise

1 reference

12 December 2020

Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin

1 reference

12 December 2020

The relation of body fat mass and distribution to markers of chronic inflammation

1 reference

12 December 2020

Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study

1 reference

12 December 2020

Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome

1 reference

12 December 2020

10.1152/AJPHEART.00206.2011

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference